CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Pouches Nicotine Free

The CBD product industry in 2026 is projected to generate tens of billions in revenue globally, most commonly estimated around $12-20 billion, with strong growth momentum. Growth is driven by: Wellness products (oils, gummies, topicals) Medical uses (pain, anxiety, epilepsy) Increasing consumer acceptance and retail availability SCOTTSDALE, AZ / ACCESS Newswire / May 5, 2026 / CBD Life Sciences Inc. (OTCID:CBDL) CBD Life Sciences Inc. is proud to announce our latest product CBD Pouches that are Nicotine Free.